Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Lindsey Devisscher
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
39
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor-spokesperson
01 January 2023 → 31 December 2026
Osteopontin and bile duct-associated macrophages in primary sclerosing cholangitis
Funding: Research Foundation - Flanders (FWO)
As
Administrative supervisor
02 January 2024 → 21 September 2025
Deciphering gut-liver axis immune cell trafficking in health and disease
Doctoral researcher: Rania Matthys
03 February 2022 → 21 September 2025
Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitis
Doctoral researcher: Lander Heyerick
03 December 2021 → 22 September 2024
In vitro and in vivo effects of microplastics on the liver
Doctoral researcher: Sybren De Boever
15 October 2021 → 21 September 2025
In vitro and in vivo investigation of the hepatotoxic potential of food additives, ingredients and supplements
Doctoral researcher: Amy Maerten
09 April 2019 → 01 December 2021
Modelling and prediction of chemical-induced human cholestatic liver injury: a mechanistic approach
Doctoral researcher: Eva Gijbels
27 April 2022 → 21 September 2025
NADPH OXIDASE 1 INHIBITION AS NEW THERAPEUTIC OPTION FOR HEPATOCELLULAR CARCINOMA
Doctoral researcher: Zenzi De Vos
13 October 2023 → 01 August 2024
The role of sex hormones in immune dysfunction in liver disease.
Doctoral researcher: Anke Kieckens
13 September 2012 → 19 June 2023
Unraveling monocyte/macrophage heterogeneity in the disturbed gut-liver axis in primary sclerosing cholangitis and ulcerative colitis
Doctoral researcher: Kevin De Muynck
As
PhD Supervisor
19 September 2024 → 21 September 2025
Doctoral project lingfeng xiong
Doctoral researcher: lingfeng xiong
13 November 2020 → 21 September 2025
Doctoral project Milton Boaheng Antwi
Doctoral researcher: Milton Boaheng Antwi
23 January 2024 → 21 September 2025
Impact of gender-affirming therapy started in early puberty on metabolic tissues
Doctoral researcher: Sandra Calvo Blanco
14 December 2024 → 21 September 2025
Impact of gender-affirming therapy started in early puberty on the kidney
Doctoral researcher: Oriana Nobus
14 May 2024 → 21 September 2025
Preclinical investigation of RNA-based cancer immunotherapies for treating hepatocellular carcinoma
Doctoral researcher: lingfeng xiong
12 September 2022 → 02 April 2023
Sex hormone signaling in hepatic metabolic memory
Doctoral researcher: Jietse Verweirder
17 November 2023 → 21 September 2025
Study of hepatitis B virus and hepatitis D virus induced liver disease
Doctoral researcher: Amse De Meyer
26 November 2018 → 05 December 2022
Targeting angiogenic and inflammatory components of the tumor microenvironment in hepatocellular carcinoma
Doctoral researcher: Bart Vanderborght
12 October 2023 → 21 September 2025
The role of hypoxia and fibrosis in acute and chronic pancreatitis
Doctoral researcher: Emine Gökce
As
Promotor
01 December 2020 → 30 November 2022
Basic research equipment for paraffin-based histology.
Funding: Regional and community funding: Special Research Fund
01 November 2022 → 31 October 2025
Cofunding core facility - Animalarium,Radiological and Radiobiological Techniques, Histology Core
Funding: Regional and community funding: Special Research Fund
01 February 2024 → 31 January 2027
Cofunding Core Facility - Patient-derived xenograft models
Funding: Regional and community funding: Special Research Fund
01 January 2024 → 31 December 2025
Exploring the role of immune cells in the gut-liver axis
Funding: Regional and community funding: Special Research Fund
01 November 2021 → 31 October 2025
Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitis
Fellow: Lander Heyerick
Funding: Research Foundation - Flanders (FWO)
01 October 2021 → 31 October 2021
Immune profiling and the role of monocyte/macrophage populations in primary sclerosing cholangitis and related ulcerative colitis.
Fellow: Lander Heyerick
Funding: Regional and community funding: Special Research Fund
01 January 2022 → 31 December 2025
NADPH OXIDASE 1 INHIBITION AS NEW THERAPEUTIC OPTION FOR HEPATOCELLULAR CARCINOMA
Funding: Funding by bilateral agreement (private and foundations)
01 June 2019 → 31 March 2024
The role of macrophages in the pathogenesis of diseases with an affected gut-liver axis
Funding: Regional and community funding: Special Research Fund
01 October 2016 → 30 September 2019
Uncovering liver macrophage subsets and the role of macrophage prolyl hydroxylases in the pathogenesis of non-alcoholic steatohepatitis and associated liver cancer
Fellows: Lindsey Devisscher
Funding: Regional and community funding: Special Research Fund
As
Copromotor
01 May 2022 → 30 April 2026
A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapies
Funding: Research Foundation - Flanders (FWO)
01 October 2020 → 30 September 2023
Crosstalk between angiogenesis and macrophages in pediatric non-alcoholic fatty liver disease
Fellow: Sander Lefere
Funding: Research Foundation - Flanders (FWO)
01 October 2023 → 30 September 2026
Maternal insulin resistance: fueling offspring fatty liver via metabolic dysregulation?
Fellow: Sander Lefere
Funding: Research Foundation - Flanders (FWO)
01 October 2022 → 30 September 2026
PSMA beyond the prostate: exploring prostate-specific membrane antigen as a target in the treatment of late-stage malignancies of the thyroid, liver and the head and neck
Funding: Funding by bilateral agreement (private and foundations)
01 May 2022 → 30 April 2026
SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomics
Funding: Research Foundation - Flanders (FWO)
01 November 2020 → 31 October 2024
The study of the therapeutic potential of PPARa-ERRa ligand combinations in non-alcoholic fatty liver disease
Fellow: Milton Boaheng Antwi
Funding: Research Foundation - Flanders (FWO)
15 December 2022 → 14 December 2024
Tissue and cell culture core facility
Funding: Regional and community funding: Special Research Fund
01 October 2016 → 30 September 2019
Uncovering liver macrophage subsets and the role of macrophage prolyl hydroxylases in the pathogenesis of non-alcoholic steatohepatitis and associated liver cancer
Fellows: Lindsey Devisscher
Funding: Regional and community funding: Special Research Fund
01 May 2022 → 30 April 2026
White light laser-based confocal fluorescence lifetime imaging microscope for multi-parameter 3D live imaging
Funding: Research Foundation - Flanders (FWO)
As
Fellow
01 January 2019 → 31 December 2019
Anti-MT antibodies as novel therapy for acetaminophen-induced liver injury.
Fellow: Lindsey Devisscher
Funding: Research Foundation - Flanders (FWO)
01 January 2017 → 30 September 2020
Foodnexus Lindsey Devisscher
Fellows: Lindsey Devisscher
Funding: Regional and community funding: Special Research Fund, Regional and community funding: various
01 October 2016 → 30 September 2019
Uncovering liver macrophage subsets and the role of macrophage prolyl hydroxylases in the pathogenesis of non-alcoholic steatohepatitis and associated liver cancer
Fellows: Lindsey Devisscher
Funding: Regional and community funding: Special Research Fund